1. Home
  2. NEPH vs FSEA Comparison

NEPH vs FSEA Comparison

Compare NEPH & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • FSEA
  • Stock Information
  • Founded
  • NEPH 1997
  • FSEA 1890
  • Country
  • NEPH United States
  • FSEA United States
  • Employees
  • NEPH N/A
  • FSEA N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • FSEA Savings Institutions
  • Sector
  • NEPH Health Care
  • FSEA Finance
  • Exchange
  • NEPH Nasdaq
  • FSEA Nasdaq
  • Market Cap
  • NEPH 60.4M
  • FSEA 54.1M
  • IPO Year
  • NEPH 2004
  • FSEA N/A
  • Fundamental
  • Price
  • NEPH $4.37
  • FSEA $11.95
  • Analyst Decision
  • NEPH Strong Buy
  • FSEA
  • Analyst Count
  • NEPH 2
  • FSEA 0
  • Target Price
  • NEPH $5.50
  • FSEA N/A
  • AVG Volume (30 Days)
  • NEPH 70.3K
  • FSEA 3.4K
  • Earning Date
  • NEPH 11-06-2025
  • FSEA 11-14-2025
  • Dividend Yield
  • NEPH N/A
  • FSEA N/A
  • EPS Growth
  • NEPH N/A
  • FSEA N/A
  • EPS
  • NEPH 0.14
  • FSEA N/A
  • Revenue
  • NEPH $17,930,000.00
  • FSEA $14,753,000.00
  • Revenue This Year
  • NEPH $24.38
  • FSEA N/A
  • Revenue Next Year
  • NEPH $10.16
  • FSEA N/A
  • P/E Ratio
  • NEPH $31.69
  • FSEA N/A
  • Revenue Growth
  • NEPH 32.36
  • FSEA 29.53
  • 52 Week Low
  • NEPH $1.39
  • FSEA $9.00
  • 52 Week High
  • NEPH $5.98
  • FSEA $11.95
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 42.66
  • FSEA 66.25
  • Support Level
  • NEPH $3.66
  • FSEA $11.50
  • Resistance Level
  • NEPH $4.72
  • FSEA $11.70
  • Average True Range (ATR)
  • NEPH 0.55
  • FSEA 0.09
  • MACD
  • NEPH -0.14
  • FSEA 0.02
  • Stochastic Oscillator
  • NEPH 35.93
  • FSEA 100.00

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About FSEA First Seacoast Bancorp Inc.

First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.

Share on Social Networks: